Sera Prognostics (SERA) EBT Margin (2020 - 2026)
Sera Prognostics' (SERA) quarterly EBT Margin came in at 77557.14% in Q1 2026, down 5520188.0% YoY from N/an in Q1 2025, and down 50.25% on a QoQ basis from 51620.0% in Q4 2025.
Sera Prognostics (SERA) EBT Margin (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of EBT Margin data on file, last reported at 77557.14% in Q1 2026.
- Quarterly EBT Margin fell 5520188.0% year-over-year to 77557.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 72024.56% (down 4221065.0% YoY) and the FY2025 annual result came in at 145618.52%, down 17956.0% from the prior year.
- EBT Margin eased to 77557.14% in Q1 2026, from 51620.0% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 9328.46% in Q2 2023 to a low of 79081.25% in Q3 2025.
- A 5-year average of 33785.16% and a median of 25472.46% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin soared 3017538 bps — and 2026, when it sank 5520188 bps.
- Tracing SERA's EBT Margin over 5 years: stood at 16055.38% in 2022, then declined by 20 bps to 19346.34% in 2023, then slumped by 89 bps to 36483.33% in 2024, then sank by 41 bps to 51620.0% in 2025, then tumbled by 50 bps to 77557.14% in 2026.
- The last three EBT Margin figures came in at 77557.14% (Q1 2026), 51620.0% (Q4 2025), and 79081.25% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 18.32% |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | -30,620.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -47,446.67% |
| Mar 31, 2026 | -77,557.14% |
| Dec 31, 2025 | -51,620.00% |
| Sep 30, 2025 | -79,081.25% |
| Jun 30, 2025 | -72,829.41% |
| Mar 31, 2025 | -22,355.26% |
| Dec 31, 2024 | -36,483.33% |
| Sep 30, 2024 | -28,589.66% |
| Jun 30, 2024 | -36,433.33% |
| Dec 31, 2023 | -19,346.34% |
| Sep 30, 2023 | -18,635.71% |
| Jun 30, 2023 | -9,328.46% |
| Mar 31, 2023 | -11,345.00% |
| Dec 31, 2022 | -16,055.38% |
| Sep 30, 2022 | -12,883.91% |
| Jun 30, 2022 | -15,252.56% |
| Mar 31, 2022 | -32,765.79% |
| Dec 31, 2021 | -46,230.77% |
| Sep 30, 2021 | -42,960.87% |
| Jun 30, 2021 | -36,805.00% |